We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App





Inexpensive Multipurpose Point-of-Care Analyzer Unveiled at 2015 AACC Annual Meeting

By LabMedica International staff writers
Posted on 29 Jul 2015
Print article
An inexpensive point-of-care (POC) instrument capable of performing multiple clinical laboratory blood tests was unveiled at the 2015 AACC Annual Meeting & Clinical Lab Expo (Atlanta, GA, USA).

Investigators from DiaSys Diagnostics India (Mumbai, India) unveiled their new QDx InstaLab POC blood chemistry device. This instrument combines inexpensive microfluidic cartridge technology with novel nanomaterial-based plastic electrochemical biosensors.

The QDx InstaLab can perform all of the clinical tests that are routinely ordered as part of a yearly physical exam to evaluate organ function and check for conditions such as diabetes, liver disease, and kidney disease. Furthermore, the instrument can determine cholesterol levels and screen for bleeding problems.

The instrument was designed to perform these tests using samples comprising a few drops of blood from a finger prick. Results are available in three to 10 minutes or less.

“In areas where cost and efficiency are of paramount importance, labs will be able to consolidate all instrumentation into a single QDx InstaLab,” said Dr. Vijaywanth Mathur, head of research and development at DiaSys Diagnostics India. “This breakthrough technology will revolutionize and enable quality healthcare for all in low to middle income and high income countries, and particularly in rural, semirural, second tier, and third tier cities where there is no access to healthcare diagnostics or the cost per test is so high.”

Related Links:

2015 AACC Annual Meeting & Clinical Lab Expo
DiaSys Diagnostics India


Gold Member
Chagas Disease Test
CHAGAS Cassette
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Piezoelectric Micropump
Disc Pump
New
Multi-Function Pipetting Platform
apricot PP5

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.